Finance

Lists
Why is 600351 down 2.17%?
Dive Deeper
600351:SHA
Yabao Pharmaceutical Group Co Ltd
CNÂ¥6.76
-2.17%
(-0.15) 1D
Nov 13, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600351...
Open
CNÂ¥6.91
High
CNÂ¥6.92
Low
CNÂ¥6.75
Mkt. cap
4.78B
Avg. vol.
26.82M
Volume
22.13M
Dividend
6.16%
Quarterly dividend
CNÂ¥0.10
Ex-dividend date
Sep 1, 2026
P/E ratio
12.86
52-wk high
CNÂ¥7.45
52-wk low
CNÂ¥5.60
EPS
CNÂ¥0.53
Shares outstanding
787.04M
No. of employees
3K
Open
CNÂ¥6.91
High
CNÂ¥6.92
Low
CNÂ¥6.75
Mkt. cap
4.78B
Avg. vol.
26.82M
Volume
22.13M
Dividend
6.16%
Quarterly dividend
CNÂ¥0.10
Ex-dividend date
Sep 1, 2026
P/E ratio
12.86
52-wk high
CNÂ¥7.45
52-wk low
CNÂ¥5.60
EPS
CNÂ¥0.53
Shares outstanding
787.04M
No. of employees
3K
News stories
From web sources and news partners
About Yabao Pharmaceutical Group Co Ltd
CEO-
Employees3.42K
Founded1978
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
531.35M
572.02M
572.92M
518.22M
Cost of goods sold
273.96M
267.45M
260.93M
229.04M
Cost of revenue
273.96M
267.45M
260.93M
229.04M
Research and development expenses
44.98M
18.35M
25.07M
28.25M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
181.71M
152.69M
175.61M
158.03M
Operating expense
261.05M
168.77M
215.41M
179.21M
Total operating expenses
535.01M
436.22M
476.34M
408.24M
Operating income
-3.66M
135.80M
96.59M
109.97M
Other non operating income
7.73M
-156.73K
-3.10M
2.90M
EBT including unusual items
121.09M
124.75M
104.56M
93.56M
EBT excluding unusual items
77.27M
137.06M
95.39M
114.51M
Income tax expense
19.69M
17.78M
32.30M
16.04M
Effective tax rate
16.26%
14.25%
30.89%
17.15%
Other operating expenses
24.39M
-1.97M
14.85M
-8.62M
Net income
104.92M
106.66M
70.93M
79.00M
Net profit margin
19.75%
18.65%
12.38%
15.24%
Earnings per share
-
-
-
-
Interest and investment income
73.62M
1.61M
2.16M
1.71M
Interest expense
-358.60K
-187.91K
-226.16K
-114.22K
Net interest expenses
73.26M
1.42M
1.94M
1.60M
Depreciation and amortization charges
-
-
-
-
EBITDA
29.78M
169.23M
126.97M
143.41M
Gain or loss from assets sale
-182.99K
-
-1.53M
1.53M
Upcoming events
AI content may include mistakes. Learn more
Google apps